Article
Targeting neuropilins as a viable SARS‐CoV‐2 treatment
29 Jun 2021
Abstract excerpt
The SARS-CoV-2 pandemic has significantly impacted global health. Research on viral mechanisms, highly effective vaccines, and other therapies is in progress. Neuropilins have recently been identified as host cell receptors enabling viral fusion. Here, we provide context to neuropilin's tissue-specific role in infection and the potential impact of NRP-based therapeutics. We conclude that the central roles of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
